India looking toward continuous manufacturing; DuPont buys Dyadic's industrial enzyme biz;

> The Indian engineering and pharma alliance STEER has created a startup to help the Indian industry move to continuous manufacturing. Report

> Florida-based protein developer Dyadic International intends to sell its industrial technology business to DuPont ($DD) for $75 million to concentrate on its pharmaceutical business. Release (PDF)

> C.O. Truxton of Bellmawr, NJ, is recalling one lot of codycycle hyalite tablets manufactured in Puerto Rico by Blu Caribe because the bar code on the bottles incorrectly scans as phenobarbital tablets. Notice

> Florida-based Quest Manufacturing is looking for OTC makers to buy to build its business. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.